Dr Dexin Kong, professor of Molecular-targeted Drug Discovery, School of Pharmaceutical Sciences, Tianjin Medical University, China, earned his BS and MS (pharmaceutical sciences) from Shandong University, China; PhD (Natural Product Chemistry, 2002-2005) from Osaka University, Japan. He served as an assistant professor in Shandong University (1996-2000). After getting his PhD, he obtained postdoctoral training as a research associate in The Chinese University of Hong Kong (2005-2006). In 2006, he moved to Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research as a scientist (2006-2009), and his position was promoted to senior scientist in 2010. In 2011, Dr Kong got his current professor position in Tianjin medical University. The major research interests of Dr Kong include molecular targeted drug discovery, molecular pharmacology, natural product chemistry and herbal medicine. Dr Kong is currently a member of AACR (American Association for Cancer Research), a member of JCA (Japanese Cancer Association). He is serving as an editorial member of several reputed journals.
Biography Updated on 19 June 2012